Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Levitzki

Showing results (221-230 of 244) with videos related to

Pageof 25
Sort By:
Cell|June 30, 1989
EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signalingB Margolis, S G Rhee, S Felder, et al.
Nuclear Medicine and Biology|June 8, 2001
Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinaseT A Bonasera, G Ortu, Y Rozen, et al.
Cancer Research|December 1, 1994
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformationM Kovalenko, A Gazit, A Böhmer, et al.
The Journal of Biological Chemistry|May 24, 2000
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activityY Zhang, J Turkson, C Carter-Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylationK E Lipson, L Pang, L J Huber, et al.
The EMBO Journal|July 1, 1986
Reconstitution of beta 1-adrenoceptor-dependent adenylate cyclase from purified componentsD Feder, M J Im, H W Klein, et al.
Cancer Research|August 15, 1991
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude miceT Yoneda, R M Lyall, M M Alsina, et al.
Oncogene|June 30, 2015
Targeting melanoma with NT157 by blocking Stat3 and IGF1R signalingE Flashner-Abramson, S Klein, G Mullin, et al.
Biochemical Pharmacology|August 3, 1994
Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesJ Markovits, A K Larsen, E Ségal-Bendirdjian, et al.
Cancer Research|September 1, 1997
Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytesH Ben-Bassat, S Rosenbaum-Mitrani, Z Hartzstark, et al.
Pageof 25

Showing results (221-230 of 244) with videos related to

Sort By:
Pageof 25
Cell|June 30, 1989
EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signalingB Margolis, S G Rhee, S Felder, et al.
Nuclear Medicine and Biology|June 8, 2001
Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinaseT A Bonasera, G Ortu, Y Rozen, et al.
Cancer Research|December 1, 1994
Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformationM Kovalenko, A Gazit, A Böhmer, et al.
The Journal of Biological Chemistry|May 24, 2000
Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activityY Zhang, J Turkson, C Carter-Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylationK E Lipson, L Pang, L J Huber, et al.
The EMBO Journal|July 1, 1986
Reconstitution of beta 1-adrenoceptor-dependent adenylate cyclase from purified componentsD Feder, M J Im, H W Klein, et al.
Cancer Research|August 15, 1991
The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude miceT Yoneda, R M Lyall, M M Alsina, et al.
Oncogene|June 30, 2015
Targeting melanoma with NT157 by blocking Stat3 and IGF1R signalingE Flashner-Abramson, S Klein, G Mullin, et al.
Biochemical Pharmacology|August 3, 1994
Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivativesJ Markovits, A K Larsen, E Ségal-Bendirdjian, et al.
Cancer Research|September 1, 1997
Inhibitors of epidermal growth factor receptor kinase and of cyclin-dependent kinase 2 activation induce growth arrest, differentiation, and apoptosis of human papilloma virus 16-immortalized human keratinocytesH Ben-Bassat, S Rosenbaum-Mitrani, Z Hartzstark, et al.
Pageof 25